QuidelOrtho Corporation QDEL recently announced the receipt of the FDA’s 510(K) clearance for its Savanna PCR (polymerization chain reaction) platform and Savanna HSV 1+2/VZV in vitro diagnostic ...

On Friday, Quidelortho Corp (QDEL) stock saw a modest uptick, ending the day at $40.14 which represents a slight increase of $2.25 or 5.94% from the prior close of $37.89. The stock opened at $37.89 ...

QuidelOrtho's revenue is shifting, with Labs growing 74% YoY, offsetting a 54% decline in Point of Care post-COVID. Explore ...

Check the time stamp on this data. Updated AI-Generated Signals for Quidelortho Corp Com (QDEL) available here: QDEL.

QuidelOrtho (QDEL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook ...

In this article, we are going to take a look at where QuidelOrtho Corporation (NASDAQ:QDEL) stands against the other oversold NASDAQ stocks. The NASDAQ soared to an all-time high on October 7 ...

SAN DIEGO, November 20, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in QuidelOrtho Corp (Symbol: QDEL), where a total of 3,882 contracts have traded so far ...